Pune, India, September, 2018 /press release/- Market Research Future Published a Half-Cooked Research Report on Lactose Intolerance Treatment Market Research Report.
Lactose Intolerance Treatment Market – Overview
Changing diet patterns worldwide have contributed to an increased level of lactose intolerance cases. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been recently put out along with a report on this industry. The market is expected to gross revenues worth $ 9.4 billion while expanding at a CAGR of 7.2 % percent approximately over the forecast period.
The market is showing tremendous potential for growth as there has been a significant rise in the availability of the types of milk products that have been developed currently. The development of lactose-free dairy, ice cream, milk formulas is adding to the overall market growth. The high digestibility of lactose-free products is expected to motivate customer demand over the forecast period, thus expanding market share.
The lactose intolerance treatment market is segmented on the basis of treatment, type and end users. On the basis of type, the market has been segmented into secondary, primary, congenital and developmental. By treatment, the market has been segmented into food supplements such as dairy, cereals, bread, enzymatic lactase supplements, fats, and milk substitutes like soy, rice, coconut, almond among others. On the basis of end users, the market has been segmented into home use, hospitals and clinics, and others.
The US is responsible for the maximum market portion owing to a promising reimbursement scenario and increased spending on healthcare. The fast market growth rate due to the discovery of new technology in the US is also a significant driver for the market for the market. The European region is the next chief market owing to huge disposable income levels and rising awareness among individuals. The Asia Pacific region is expected to have the most potential, and it is projected to be led by China and India. The Middle East & Africa market is led by the Gulf nations chiefly such as Saudi Arabia and UAE.
The improvement in the products and services is the fundamental factor in increasing the market's output and is influencing the trends that are gaining importance in the market. The dominant success factors and players’ tendencies are gradually enhanced by the strategies that are being used by market contenders. The market has initiated a new period of development as the market is constantly in a state of variability. The obtainability of a proper labor force along with resources is contributing to the market growth particularly. The external factors are influencing the market expansion which is dependant on the practices and the strategic roadmaps that are used by market companies.
The important players studied in the report are National Enzyme Company, Johnson & Johnson Inc., Daiya Foods Inc., Ganeden Biotech, Arla Foods, Vetbiochem India Private Limited, Scimera Partners, Oberland-Milchverwertung (OMIRA), McNeil Nutritionals, Parmalat, Valio, and others.
June 2018 Ritter Pharmaceuticals, Inc. has recently announced that RP-G28, a drug candidate which can be the first FDA-approved treatment for lactose intolerance (LI), has enrolled its first patient in the first pivotal Phase 3 clinical trial of RP-G28.